Mesenchymal stem cell (MSC) transplantation improves recovery from ischemic stroke in
animals. We examined the feasibility, efficacy, and safety of cell therapy using culture …

We previously evaluated the short-term follow-up preliminary data of mesenchymal stem
cells (MSCs) transplantation in patients with ischemic stroke. The present study was …

Parkinson's disease (PD) and multiple system atrophy (MSA) are neurodegenerative
diseases representative of α-synucleinopathies characterized pathologically by α-synuclein …

Current evidence suggests a central role for autophagy in Alzheimer disease (AD), and
dysfunction in the autophagic system may lead to amyloid-β (Aβ) accumulation. Using in …

Parkinson's disease (PD) is a common, progressive neurodegenerative disorder caused by
the loss of dopaminergic neurons in the substantia nigra (SN). Numerous studies have …

Objective: Neuroprotective or regenerative strategies are invaluable in multiple system
atrophy (MSA) due to its rapid progression with fatal prognosis. We evaluated the efficacy of …

Background and Purpose—The pathogenesis of internal border-zone (IBZ) and cortical
border-zone (CBZ) infarcts is unclear. Both types of infarct have been combined into a single …

The concept of cognitive reserve (CR) in Alzheimer's disease (AD) explains the differences
between individuals in their susceptibility to AD-related pathologies. An enhanced CR may …

Parkinson's disease is a common progressive neurodegenerative disorder caused by the
loss of dopaminergic neurons in the substantia nigra. We investigated whether cell therapy …

Background: Cognitive dysfunction is common in Parkinson's disease (PD), and along with
PD with dementia (PDD), the concept of mild cognitive impairment in PD (PD‐MCI) has been …